Nutrients · 2024 · 17 citations · 11 references
MedicineOncologyPharmacologyCancer PharmacologyCellular MetabolismDrug DiscoveryAntioxidant DefenseBrain TumorsCancer MetabolismGlioblastomaMetabolic ReprogrammingMetabolic Reprogramming In CancerAnticancer ActivityAnticancer Drug ResistanceAnticancer Natural ProductsGlioblastoma Drug TherapyGlioblastoma MigrationGlioblastoma Therapeutic ResistanceOxidative Stress In CancerProliferative Quiescence
Glioblastoma (GBM) is a severe form of brain tumor that has a high fatality rate. It grows aggressively and most of the time results in resistance to traditional treatments like chemo- and radiotherapy and surgery. Biodiversity, beyond representing a big resource for human well-being, provides several natural compounds that have shown great potential as anticancer drugs. Many of them are being extensively researched and significantly slow GBM progression by reducing the proliferation rate, migration, and inflammation and also by modulating oxidative stress. Here, the use of some natural compounds, such as Allium lusitanicum, Succisa pratensis, and Dianthus superbus, was explored to tackle GBM; they showed their impact on cell number reduction, which was partially given by cell cycle quiescence. Furthermore, a reduced cell migration ability was reported, accomplished by morphological cytoskeleton changes, which even highlighted a mesenchymal–epithelial transition. Furthermore, metabolic studies showed an induced cell oxidative stress modulation and a massive metabolic rearrangement. Therefore, a new therapeutic option was suggested to overcome the limitations of conventional treatments and thereby improve patient outcomes.
11
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Roger Stupp, Warren Mason, Martin J. van den Bent et al. · New England Journal of Medicine · 2005 · 21.6K citations · Full text
Sunyoung Ham, Ki Hong Kim, Tae Ho Kwon et al. · Oncology Reports · 2014 · 58 citations · Full text